NCT06887673 2025-03-20Lipid Mediators & Cancer: Montelukast, SPM, and AlmondsUniversity of South FloridaPhase EARLY_PHASE1 Not yet recruiting56 enrolled
NCT04906382 2025-02-13Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial CancerOhio State University Comprehensive Cancer CenterPhase EARLY_PHASE1 Terminated2 enrolled